Embecta receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Embecta Corp (EMBC)
Embecta Corp stock price live, this page displays NASDAQ EMBC stock exchange data. View the EMBC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Embecta Corp real time stock price chart below.
What Is the Embecta Corp Stock Price Today?
The Embecta Corp stock price today is 11.73.
What Is the Stock Symbol for Embecta Corp?
The stock symbol for Embecta Corp is ""EMBC.""
What Stock Exchange Does Embecta Corp Trade On?
Embecta Corp is listed and trades on the NASDAQ stock exchange.
Is Embecta Corp a Good Stock to Buy?
Determining whether Embecta Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EMBC quote. (ISIN: US29082K1051)
What Is the Embecta Corp Stock Price Today?
The Embecta Corp stock price today is 11.73.
What Is the Stock Symbol for Embecta Corp?
The stock symbol for Embecta Corp is ""EMBC.""
What Stock Exchange Does Embecta Corp Trade On?
Embecta Corp is listed and trades on the NASDAQ stock exchange.
Is Embecta Corp a Good Stock to Buy?
Determining whether Embecta Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EMBC quote. (ISIN: US29082K1051)
NASDAQ
Currency in USD
11.73
+0.35(+3.08%)
Closed·
After Hours
11.730.00(0.00%)
·
Fair Value
An estimate of a Embecta's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.32
11.77
52 wk Range
9.20
21.48
EMBC Scorecard
Full Analysis
High shareholder yield
Earnings results expected in 12 days
More Info
Fair Value
An estimate of a Embecta's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.3211.77
52 wk Range
9.2021.48
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.12%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.12%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EMBC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Embecta's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
18.33
Upside
+56.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- BofA cuts Embecta stock price target to $18 from $20
- Investing.com
- Embecta receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Embecta Corp Company Profile
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Embecta Corp Earnings Call Summary for Q2/2025
- Q2 FY2025 EPS of $0.70 beat forecast by 32%, but revenue declined 9.8% YoY to $259M amid market challenges
- Stock dipped 2.18% pre-market despite earnings beat, reflecting investor concerns over declining revenue
- Company maintains strong margins with 63.7% adjusted gross profit and 37.5% adjusted EBITDA
- Full-year guidance projects revenue of $1,073M-$1,090M and adjusted EPS of $2.70-$2.90
- Ongoing restructuring and phased execution of strategic programs aim to address market challenges
Last Updated: 09/05/2025, 14:06
Read Full TranscriptCompare EMBC to Peers and Sector
Metrics to compare | EMBC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEMBCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.0x | −11.6x | −0.5x | |
PEG Ratio | −0.48 | −0.33 | 0.00 | |
Price/Book | −0.9x | 3.1x | 2.6x | |
Price / LTM Sales | 0.6x | 4.1x | 3.2x | |
Upside (Analyst Target) | 53.5% | 50.3% | 41.4% | |
Fair Value Upside | Unlock | 0.0% | 6.0% | Unlock |
Analyst Ratings
1 Buy
2 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 18.33
(+56.29% Upside)
Earnings
Latest Release
May 09, 2025
EPS / Forecast
0.70 / 0.53
Revenue / Forecast
259.00M / 253.86M
People Also Watch
FAQ
What Stock Exchange Does Embecta Trade On?
Embecta is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Embecta?
The stock symbol for Embecta is "EMBC."
What Is the Embecta Market Cap?
As of today, Embecta market cap is 685.53M.
What Is Embecta's Earnings Per Share (TTM)?
The Embecta EPS (TTM) is 0.91.
When Is the Next Embecta Earnings Date?
Embecta will release its next earnings report on 07 Aug 2025.
From a Technical Analysis Perspective, Is EMBC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Embecta Stock Split?
Embecta has split 0 times.
How Many Employees Does Embecta Have?
Embecta has 2100 employees.
What is the current trading status of Embecta (EMBC)?
As of 27 Jul 2025, Embecta (EMBC) is trading at a price of 11.73, with a previous close of 11.38. The stock has fluctuated within a day range of 11.32 to 11.77, while its 52-week range spans from 9.20 to 21.48.
What Is Embecta (EMBC) Price Target According to Analysts?
The average 12-month price target for Embecta is USD18.33333, with a high estimate of USD25 and a low estimate of USD12. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +56.29% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.